top of page
PASSRACGP Logo_white.png

Progress

0%

Cardiovascular

Fibromyalgia


Pertinent History

  • Symptoms: Widespread soft tissue pain, fatigue, unrefreshing sleep, "fibrofog" (poor concentration)

  • Associated Conditions: Mood disorders (anxiety, depression), irritable bowel/bladder symptoms

  • Chronicity: Symptoms persist ≥3 months


Examination

  • Tenderness: Soft tissue points (e.g., lateral condyles, trapezius)

  • Allodynia: Pain with light touch or BP cuff inflation

  • Normal Findings: Joint and systemic exam normal


Diagnosis

  • Criteria (ACR 2010/2016):

    • Widespread Pain Index (WPI) ≥7 and Symptom Severity Score (SSS) ≥5 OR

    • WPI 3–6 and SSS ≥9

  • No alternative explanation for symptoms

  • Labs/imaging only to exclude other causes

____________________________________


Management


Non-Pharmacological:

  • Exercise: Gradual aerobic or hydrotherapy-based programmes

  • Psychological: CBT and mindfulness for pain coping/stress

  • Sleep Hygiene: Fixed schedule, minimise disturbances

  • Support: Refer to fibromyalgia support groups, multidisciplinary input


Pharmacological:

  • First Line: Low-dose TCAs (e.g., amitriptyline 10–25 mg nocte)

  • Second Line: Duloxetine or pregabalin (dose titration based on tolerance)

  • Avoid Opioids: Except tramadol in specialist contexts

  • Goal: Improve functionality, not eliminate pain


Counselling Points

  • Pain is real but not due to tissue damage

  • Symptoms may fluctuate; condition is not progressive

  • Treatment aims to improve function, not eliminate pain

  • Emphasise adherence to long-term management


Red Flags

  • New onset in older age

  • Focal pain or neurological signs

  • Systemic symptoms: Weight loss, fever, night sweats

  • May indicate alternative pathology


When to Refer

  • Atypical presentation or refractory symptoms

  • Significant psychosocial or psychological comorbidities


Differentials

  • Rheumatoid arthritis (RA)

  • Polymyalgia rheumatica (PMR)

  • Chronic fatigue syndrome (CFS)

  • Hypothyroidism

  • Sleep apnoea


Complications

  • Functional impairment, diminished quality of life

  • Secondary depression and anxiety


Notes

  • Overlap: Often coexists with RA, SLE, or other chronic illnesses

  • First-line drug: Low-dose TCAs (improve sleep and pain)

  • If TCAs fail: Consider gabapentinoid or SNRI (duloxetine)

Bookmark Failed!

Bookmark Saved!

bottom of page